Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ARCHER MATERIALS LIMITED AGM Information 2023

Nov 28, 2023

64478_rns_2023-11-28_ad15ed6d-013c-4371-a83e-04c205b97762.pdf

AGM Information

Open in viewer

Opens in your device viewer

AGM Presentation

==> picture [68 x 69] intentionally omitted <==

==> picture [120 x 120] intentionally omitted <==

----- Start of picture text -----

November
2023
----- End of picture text -----

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

2022/23 Achievements

==> picture [716 x 252] intentionally omitted <==

----- Start of picture text -----

Commenced Progressed Partnered with the Detected quantum
working with international World Economic information in the
world-leading patent applications and Forum’s Centre for 12CQ qubit material
and tier-one patent grants the Fourth Industrial on-chip and at room
semiconductor in relation to the Revolution as temperature for the
manufacturers 12CQ chip and Australia’s first first time using CMOS
towards industry biochip industry representative technology.
fabrication of technologies. alongside other
Archer’s technology. advanced technology
centres.
Advanced the Validated the key Developed an Gained commercial
room temperature tech-enabling quantum early-stage prototype access to world class
capabilities and phenomena observed of an integrated semiconductor
functionality of the in the [12] CQ qubit biochip system fabrication infrastructure
12CQ qubit material material using some platform for biosensing and facilities, and
while achieving of the most powerful with automated liquid technical experts in
unprecedented supercomputers sample handling Australia and
quantum coherence in the world. and readout. internationally to
times. develop Archer’s
technology.
----- End of picture text -----

2

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

Archer has the foundations in place to advance its semiconductor development towards commercialisation in global markets.

==> picture [240 x 120] intentionally omitted <==

==> picture [61 x 60] intentionally omitted <==

==> picture [61 x 60] intentionally omitted <==

==> picture [61 x 60] intentionally omitted <==

==> picture [61 x 60] intentionally omitted <==

==> picture [61 x 60] intentionally omitted <==

==> picture [61 x 60] intentionally omitted <==

Access to $1B+ Efficient use of Patents granted Deep technology of deep-tech funds with A$21.3M in the US, China, development infrastructure cash and no debt South Korea, backed by and facilities. as of 30 Sept 2023. Japan, Hong Kong, world-class R&D. Australia, and Europe.

Partnered with Attracting and tier-one foundries, retaining pioneering tech institutes, innovators and international technologists. organisations and companies.

3

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

Archer utilises its global partnerships to develop its technologies for potential deployment and use across multiple industries.

Archer’s world-first 12CQ chip development involves qubit integration with modern devices made in industrial foundries. HEMT and CMOS integrated circuit technology devices have been used to detect quantum information in the 12CQ qubit material at room-temperature.

Advanced designs of Archer’s biochip graphene field effect transistor sensor technology have undergone scalable semiconductor processing in a commercial foundry. Whole wafer and MPW runs have been completed with foundry partners in Europe.

==> picture [239 x 120] intentionally omitted <==

==> picture [716 x 168] intentionally omitted <==

----- Start of picture text -----

Competitive R&D Fabless Design / MPW / Full Mask Package & Testing Qualification Mass Commercial
Prototyping Assembly Development Production Activation
Phase 1 - Design Phase 2 - Development Phase 3 - Industrialisation
Supply chain management
----- End of picture text -----

4

AGM Presentation November 2023

Archer continues to progress towards making quantum processing devices in a much more easily-produced reality in everyday electronics.

==> picture [269 x 155] intentionally omitted <==

==> picture [120 x 121] intentionally omitted <==

==> picture [40 x 41] intentionally omitted <==

Q4 Q1 Q2 Q3 Q4 Q1 FY22 FY23 FY23 FY23 FY23 FY24 Complex nanodevices The successful grant of Quantum information in Engagement with tierArcher engineers its Design and build of Substantial progress in fabricated in first steps all 12CQ chip patent Archer’s qubit material one semiconductor qubit material giving microwave circuitry for innovation at the forefront towards qubit control applications in Archer’s detected using CMOS companies, including rise to unprecedented readout devices, of international quantum and readout, linking current portfolio across technology (above), and TSMC, to secure future quantum functionality validated using development. directly to qubit Australasia, Europe, and supercomputers manufacturing at room temperature in electromagnetic operation. the US. validate qubit material capabilities. air. simulation software. uniqueness.

5

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

Archer's Biochip technology uses graphene transistors as miniaturised and ultrasensitive sensors to detect and analyse disease.

==> picture [223 x 121] intentionally omitted <==

Q4 Q1 Q2 Q3 Q4 Q1 FY22 FY23 FY23 FY23 FY23 FY24 Archer develops Goal of sub-10nm feature An operational, early Electronic control of the gFET design transfer to Commercial foundry Continued innovation biochemical reactions size fabrication reached stage, end-to-end sensitivity of incorporated a foundry partner after partner in the Netherlands towards integrating with the potential for onin Archer’s biochip prototype system gFET devices achieved, Archer develops an optical validates Archer’s more functionality on the chip DNA/RNA development, applicable platform built, and Archer critical for the selective lithography-compatible advanced biochip gFET biochip, and optimising detection, and has for a broad potential seeks patent protection detection of target chip layout, designed design with whole fourdevice manufacture in integrated graphene on sensing applications. internationally molecules. for whole-wafer scale inch wafer fabrication commercial foundries. a silicon wafer. production processes.

6

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

Archer is primed to become a global semiconductor company

The future of tech will look fundamentally different

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
Archer continues to de-risk its
technology and enters FY24 with a
strong cash balance to fund
continued technological and
commercial developments.
In 2023/24,
Archer’s growth
involves:
Technology
Progressing world-
frst technology
development,
including12CQ
qubit processor
chip and graphene-
based lab-on-a-chip
biochip.
Partnerships
Establishing and
strengthening strategic
commercial partnerships,
including securing
future semiconductor
manufacturing
capabilities advancing
technology development.
Innovation
Utilising world-class
technology development
infrastructure and
facilities, R&D, people,
and IP, to support pre-
market development.
Patents
Protecting intellectual
property (e.g., patents and
international patent
applications) with global
competitive advantages
to underpin innovative
technology.
Talent
Hiring new staf to
expedite developing
and working towards
commercialising the
Company’s technology.

8

AGM Presentation November 2023

==> picture [240 x 120] intentionally omitted <==

Archer’s technology innovation aims to solve long-standing human problems that can’t be solved using existing technology.

Tier-one supplychain links.

Global competitive advantage worth protecting.

The future of tech.

Talented team to rival any.

Archer is the only ASX listed company and one of a few players in the semiconductor industry with patents protecting qubit processor technology.

Archer’s complementary quantum devices offer the potential to overcome significant limitations in traditional digital technologies.

Archer’s partnerships are strong with clear goals. We work with multinationals, startups, and leading R&D labs around the world.

Archer is developing advanced semiconductor devices based on the breakthrough scientific discoveries of our staff.

The Company has a growing IP portfolio of granted and pending patents for potentially commercialising step-change advances in it’s R&D Programs.

==> picture [40 x 41] intentionally omitted <==

Activities with significant impact.

Archer has a solid track record delivering on ambitious goals, with a strong pipeline of ‘news flow’ expected over the next year.

Archer is part the wider global ecosystem of the semiconductor industry

9

AGM Presentation November 2023

==> picture [40 x 41] intentionally omitted <==

Disclaimer

==> picture [120 x 120] intentionally omitted <==

The material contained in this document is a presentation of general information about the activities of Archer Materials Ltd and its related bodies corporate (together the “Archer Group”), current as at the date of this presentation. It is provided in summary and does not purport to be complete. You should not rely upon it as advice for investment purposes, as it does not take into account your investment objectives, financial position or needs. These factors should be considered, with or without professional advice, when deciding if an investment is appropriate. To the extent permitted by law, no responsibility for any loss arising in any way (including by way of negligence) from anyone acting or refraining from acting as a result of this material is accepted by the Archer Group, including any of its related bodies corporate.

This document may contain forward-looking statements with respect to the financial condition, results of operations, and business strategy of the Archer Group. These forward-looking statements are based on estimates, projections and assumptions made by the Archer Group about circumstances and events that have not yet taken place. Although the Archer Group believes the forward-looking statements to be reasonable, they are not certain. Forward-looking statements involve known and unknown risks, uncertainties and other factors that are in some cases beyond the Archer Group’s control, and which may cause actual results, performance or achievements to differ materially from those expressed or implied by the forward-looking statements (and from past results). The Archer Group makes no representation or warranty as to the accuracy of any forward-looking statements in this presentation and undue reliance should not be placed upon such statements. Forward-looking statements may be identified by words such as “aim”, “anticipate”, “assume”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “plan”, “predict”, “should”, “will”, or “would” or the negative of such terms or other similar expressions that are predictions of or otherwise indicate future events or trends. The forward-looking statements included in this presentation speak only as of the date of this presentation. The Archer Group does not intend to update the forward-looking statements in this presentation in the future.

This presentation contains information which was reported in ASX announcements lodged between 1 October 2017 and 28 November 2023 (together the “Announcements”). All material assumptions and technical parameters set out in the Announcements continue to apply and have not materially changed. The Announcements can be viewed online at https://www.archerx.com.au.

Certain statistical and other information included in this presentation is sourced from publicly available third party sources and has not been independently verified.

10

ASX Code: AXE

The Board of Archer authorised this announcement to be given to ASX.

==> picture [89 x 90] intentionally omitted <==

Stay in touch atest news, reports and presentations

Archer Materials Limited (ABN 64 123 993 233)

Adelaide

San Francisco

Lausanne

Sydney

SIP West EPFL, Level 4, 575 Market EPFL Innovation St, San Francisco, Park, Lausanne 1015, California 94105, Switzerland USA

The Quantum Lot Fourteen, Terminal, Haymarket Frome Road, NSW 2000 Adelaide SA 5000, Australia Australia

E: [email protected] Visit us at: archerx.com.au

Shareholders are encouraged to take advantage of the benefits of electronic communications by electing to receive communication from the Company and its share registry electronically.

Shareholders can change their communication preferences through the registry website: www.investorcentre.com

For more information about Archer’s activities, and sign up to receive the latest news, reports, presentations and ASX released, please visit the following:

Twitter

YouTube

www.twitter.com/archerxau?lang=en https://bit.ly/2UKBBmG LinkedIn www.linkedin.com/company/archerxau http://eepurl.com/dKosXI

Sign up to our Newsletter